Cash Flow from Operating Activities: A company's cash flows from operations.
Cyclerion Therapeutics, Inc. (CYCN) had Cash Flow from Operating Activities of $-3.31M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$2.07M |
|
$-3.53M |
|
-- |
|
$2.07M |
|
$7.05M |
|
$-4.97M |
|
$1.45M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-4.97M |
|
$-4.97M |
|
3.18M |
|
3.18M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$4.63M |
|
-- |
|
$5.35M |
|
$9.98M |
|
$0.90M |
|
-- |
|
-- |
|
$0.90M |
|
$9.09M |
|
$9.09M |
|
$9.09M |
|
3.82M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-3.31M |
$0.00M |
|
$3.32M |
|
$3.23M |
|
$3.24M |
|
$0.01M |
|
$0.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.15 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-239.78% |
|
-239.78% |
|
-239.78% |
|
-170.11% |
|
-170.11% |
|
$-3.31M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
-- |
|
2.07 |
|
175.99 |
|
-38.83% |
|
-38.83% |
|
-35.33% |
|
-38.83% |
|
$2.38 |
|
$-1.04 |
|
$-1.04 |
|